Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Engagement and Opportunities to Optimize CAB-LA as Pre-exposure Prophylaxis (PrEP) for Women Who Inject Drugs

NCT05799339 is registered in ClinicalTrials.gov with Alexis Roth as lead sponsor.

NCT NCT05799339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05799339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Engagement and Opportunities to Optimize CAB-LA as Pre-exposure Prophylaxis (PrEP) for Women Who Inject Drugs
Lead sponsor
Alexis Roth
Phase
Observational
Overall status
Completed
Start date
January 13, 2022
Completion date
July 31, 2025
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, opioid use, trauma, psychological